Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth.

Area of Science:

• Child and Adolescent Psychiatry
• Clinical Psychology
• Psychopharmacology

Background:

• Major depressive disorder (MDD) in youth has high relapse rates (30-40%) within 1-2 years post-acute treatment.
• Existing pharmacotherapy for acute MDD in youth shows rapid symptom reduction but often leaves residual symptoms, contributing to relapse.
• Adult studies suggest psychosocial augmentation post-medication can enhance response and prevent relapse, a strategy yet unexamined in pediatric depression.

Purpose of the Study:

• To develop and pilot a sequential, combination treatment strategy for promoting rapid remission and preventing relapse in depressed youth.
• To adapt cognitive behavioral therapy (CBT) for relapse prevention (RP-CBT) in pharmacotherapy-responsive youth.
• To establish the feasibility, tolerability, and preliminary efficacy of RP-CBT in a pediatric population.

Main Methods:

• Development of a novel relapse prevention therapy (RP-CBT) adapted from CBT principles.
• Adaptation focused on preventing relapse, enhancing wellness, and building skills for sustained emotional health.
• Initial feasibility and tolerability assessment in a small open-series sample of depressed youth.

Main Results:

• The developed RP-CBT was found to be feasible for implementation in youth with depression.
• Youth participating in the RP-CBT intervention demonstrated good tolerability of the treatment.
• Preliminary data suggests potential for RP-CBT to address relapse prevention in this population.

Conclusions:

• RP-CBT presents a promising novel approach for preventing relapse in youth with MDD following acute treatment.
• The intervention is feasible and well-tolerated by adolescents, supporting further investigation.
• A future randomized controlled trial is warranted to rigorously test the efficacy of RP-CBT.